Search
SOLACI Congress
Presentations

CoreValve for High Risk and Extreme Risk Patients; The US Pivotal Trials

solaci
solaci
170
0

7_eduardo_de-marchena
Eduardo de Marchena
2014-10-30

M.D., F.A.C.C., F.A.C.P., F.S.C.A.I.
Professor of Medicine & Surgery
Associate Dean for International Medicine
Director of Interventional Cardiology
University of Miami Miller School of Medicine

Previous article
Insuficiencia Aórtica post TAVI
Next article
Orbital Atherectomy
solaci
solaci

More articles by this author

Stroke

solaci - 0
Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands

Intervencionismo Coronario en Venas Centrales

solaci - 0
Jorge Villegas2014-10-30Cardiólogo IntervencionistaProfesor: F.U.C.S.Jefe de Hemodinmia Hospital Universitario Clínica San Rafael

TAVI-Induced Conduction Abnormalities

solaci - 0
Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands

In Perspective: Impact of new TAVI Devices on TAVI Complications

solaci - 0
Eberhard Grube2014-10-30MD, FACC, FSCAIUniversity Hospital, Dept of Medicine II, Bonn, GermanyStanford University, Palo Alto, California, USA 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Stroke

Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands
solaci -
SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy